Jefferies Group's EXAS Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 57,816 shares of Exact Sciences Corporation (EXAS) worth $5.87 M, representing 0.03% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 60,458 shares. Largest reduction occurred in Q4 2023, reducing 32,894 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +13,500 | Add 30.46% | 57,816 | $101.56 |
| Q3 2025 | -2,684 | Reduce 5.71% | 44,316 | $54.71 |
| Q2 2025 | -20,000 | Reduce 29.85% | 47,000 | $53.14 |
| Q1 2025 | -8,545 | Reduce 11.31% | 67,000 | $43.29 |
| Q4 2024 | -21,205 | Reduce 21.92% | 75,545 | $56.19 |
| Q3 2024 | -16,000 | Reduce 14.19% | 96,750 | $68.12 |
| Q2 2024 | +45,292 | Add 67.14% | 112,750 | $42.25 |
| Q1 2024 | +60,458 | Add 863.69% | 67,458 | $69.06 |
| Q4 2023 | -32,894 | Reduce 82.45% | 7,000 | $73.98 |
| Q3 2023 | -12,715 | Reduce 24.17% | 39,894 | $68.22 |
| Q2 2023 | -11,302 | Reduce 17.68% | 52,609 | $93.90 |
| Q1 2023 | +37,594 | Add 142.85% | 63,911 | $67.81 |
| Q4 2022 | +26,317 | New Buy | 26,317 | $49.51 |
Jefferies Group's Exact Sciences Corporation Investment FAQs
Jefferies Group first purchased Exact Sciences Corporation (EXAS) in Q4 2022, acquiring 26,317 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Exact Sciences Corporation (EXAS) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to Exact Sciences Corporation (EXAS) was in Q1 2024, adding 67,458 shares worth $4.66 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 57,816 shares of Exact Sciences Corporation (EXAS), valued at approximately $5.87 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.03% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Exact Sciences Corporation (EXAS) was 112,750 shares, as reported at the end of Q2 2024.